Trial intelligence / Profile preview

Single-dose methadone and buprenorphine effects on driving performance and cognition

NL-OMON43288Active, not recruiting

Sponsor
Maastricht University
Start
Nov 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of methadone and buprenorphine in opioid use disorder (OUD) and pain (5 arms), sponsored by Maastricht University. Primary endpoints: Driving performance and Cognition. Started Nov 2016; status: active, not recruiting.

02

Drugs

methadonebuprenorphine
03

Conditions

opioid use disorder (OUD)pain

Beyond the preview

Go deeper on NL-OMON43288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call